Veracyte Inc
NASDAQ:VCYT

Watchlist Manager
Veracyte Inc Logo
Veracyte Inc
NASDAQ:VCYT
Watchlist
Price: 37.04 USD -6.3% Market Closed
Market Cap: 2.8B USD
Have any thoughts about
Veracyte Inc?
Write Note

Veracyte Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Veracyte Inc
Accrued Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Veracyte Inc
NASDAQ:VCYT
Accrued Liabilities
$51.2m
CAGR 3-Years
16%
CAGR 5-Years
36%
CAGR 10-Years
24%
Abbvie Inc
NYSE:ABBV
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Accrued Liabilities
$14.6B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accrued Liabilities
$2.5B
CAGR 3-Years
7%
CAGR 5-Years
25%
CAGR 10-Years
24%

See Also

What is Veracyte Inc's Accrued Liabilities?
Accrued Liabilities
51.2m USD

Based on the financial report for Sep 30, 2024, Veracyte Inc's Accrued Liabilities amounts to 51.2m USD.

What is Veracyte Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
24%

Over the last year, the Accrued Liabilities growth was 29%. The average annual Accrued Liabilities growth rates for Veracyte Inc have been 16% over the past three years , 36% over the past five years , and 24% over the past ten years .

Back to Top